Boehringer enters into cancer drug development deal with Enara Bio
Boehringer Ingelheim has entered into a strategic collaboration and licensing agreement with Enara Bio to...
Bayer signs Covid-19 vaccine development deal with CureVac
Bayer has entered into a collaboration and services agreement with German biopharmaceutical company CureVac to...
Singapore approves Pfizer and BioNTech’s Covid-19 vaccine
Singapore has approved the Covid-19 vaccine by Pfizer and its German partner BioNTech, as well...
Boehringer to acquire NBE-Therapeutics for $1.43bn
Boehringer Ingelheim has signed a binding agreement to acquire all shares of clinical-stage Swiss biotechnology...
Gilead Sciences to acquire German biotech firm MYR for $1.4bn
Gilead Sciences has signed a definitive agreement to acquire German biotechnology company MYR for approximately...
Boehringer to acquire German biotech firm Labor Dr Merk & Kollegen
Boehringer Ingelheim has signed an agreement to acquire all the shares of Germany-based biotech company...
Pfizer, BioNTech to seek FDA EUA for Covid-19 vaccine candidate
Pfizer and BioNTech are set to submit an application to the US Food and Drug...
Pfizer, BioNTech’s final Covid-19 vaccine study shows 95% efficacy
Pfizer and BioNTech have concluded the Phase III study of their mRNA-based Covid-19 vaccine candidate,...
Boehringer expands oncology partnership with Oxford BioTherapeutics
Boehringer Ingelheim has announced the expansion of its partnership with UK-based Oxford BioTherapeutics (OBT) to discover...